Serum Concentrations of Some Thelper1-Derived Cytokines in Generalized Erythema Multiforme

Tran Thi  Huyen; Pham Thi Minh  Phuong; Le Huu  Doanh; Pham Thi  Lan; Nguyen Thi Ha  Vinh

doi:10.3889/oamjms.2023.11706

Authors

Tran Thi Huyen Department of Dermatology and Venereology, Hanoi Medical University, Hanoi, Vietnam; Department of Outpatient, National Hospital of Dermatology and Venereology, Hanoi, Vietnam https://orcid.org/0000-0002-9794-5718
Pham Thi Minh Phuong Department of Outpatient, National Hospital of Dermatology and Venereology, Hanoi, Vietnam https://orcid.org/0000-0003-1509-599X
Le Huu Doanh Department of Dermatology and Venereology, Hanoi Medical University, Hanoi, Vietnam; Department of Outpatient, National Hospital of Dermatology and Venereology, Hanoi, Vietnam
Pham Thi Lan Department of Dermatology and Venereology, Hanoi Medical University, Hanoi, Vietnam; Department of Outpatient, National Hospital of Dermatology and Venereology, Hanoi, Vietnam
Nguyen Thi Ha Vinh Department of Dermatology and Venereology, Hanoi Medical University, Hanoi, Vietnam; Department of Outpatient, National Hospital of Dermatology and Venereology, Hanoi, Vietnam https://orcid.org/0000-0001-6066-363X

DOI:

https://doi.org/10.3889/oamjms.2023.11706

Keywords:

Erythema multiforme, Herpes simplex virus, Interferon-gamma, Interleukin-2, Tumor necrosis factor, Mycoplasma pneumoniae

Abstract

BACKGROUND: Erythema multiforme (EM) is an acute mucocutaneous syndrome characterized by typical and/or atypical target lesions on the skin. The etiology is still not clear, but EM may be related to infection or medication. Clinically, there are cases of EM with atypical target lesions with generalized distribution without, or with minimal, mucosal lesions. The causes remain unknown. However, T helper cells 1 (Th1) may play an important role in EM.

AIMS: The aim of the study was to investigate serum concentrations of some Th1-derived cytokines in generalized EM or generalized EM -like eruptions.

METHODS: This was a sectional and descriptive study conducted at the National Hospital of Dermatology and Venereology, in Hanoi, Vietnam, from April 2017 to August 2019. There were 33 EM patients, and 32 healthy controls (HCs) participated. Serum interleukin (IL)-2, interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α) levels were measured using the fluorescence covalent microbead immunosorbent assay (ProcartaPlex Immunoassay Panels kit, Thermo Fisher Scientific, USA). The Mann–Whitney U-test was used to compare the serum IL levels of the two groups. Differences were considered to be statistically significant at p < 0.05.

RESULTS: The mean age of the EM patients was 42.2 ± 17.5 years, ranging from 19 to 76 years old. Men accounted for 30.3%, women accounted for 69.7%. There were 22 patients with <1 week of onset, accounting for 66.7%; 11 patients with 1 week and those with more than 1 week accounted for 33.3%. There were 60.6% of patients using drugs before the onset. Most patients had pruritus (97%), and all had diffusely distributed skin lesions. Only 15.2% of the patients had mucosal lesions. There are 30.3% of patients with fever. The serum IFN-γ concentration of the EM group was 5.35 ± 9.88 pg/mL, higher than that of the HCs group (0.35 ± 0.77 pg/mL), the difference was statistically significant with p = 0.01 (Mann–Whitney U). The concentrations of IL-2 and TNF-α of the HCs were 24.32 ± 27.94 pg/mL and 109.74 ± 126.73 pg/mL, respectively, higher than those of the EM group (3.37 ± 5.94 pg/mL and 5.86 ± 11.88 pg/mL, respectively). The difference was statistically significant with p < 0.001. Age did not correlate with serum concentrations of cytokines in the EM group.

CONCLUSION: In generalized EM, serum concentrations of IFN-γ are statistically significantly higher than those of HCs but serum concentrations of IL-2 and TNF-α were lower. There is no correlation between age and serum concentrations of cytokines in generalized erythema multiform.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Roujeau JC, Mockenhaupt M. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw Hill Education; 2019. p. 159-92.

Brice SL, Krzemien D, Weston WL, Huff JC. Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme. J Invest Dermatol. 1989;93(1):183-7. https://doi.org/10.1111/1523-1747.ep12277397 PMid:2545789 DOI: https://doi.org/10.1111/1523-1747.ep12277397

Ng PP, Sun YJ, Tan HH, Tan SH. Detection of herpes simplex virus genomic DNA in various subsets of Erythema multiforme by polymerase chain reaction. Dermatology. 2003;207(4):349-53. https://doi.org/10.1159/000074112 PMid:14657624 DOI: https://doi.org/10.1159/000074112

Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129(1):92-6. PMid:8420497 DOI: https://doi.org/10.1001/archderm.129.1.92

Canavan TN, Mathes EF, Frieden I, Shinkai K. Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic review. J Am Acad Dermatol. 2015;72(2):239-45. https://doi.org/10.1016/j.jaad.2014.06.026 PMid:25592340 DOI: https://doi.org/10.1016/j.jaad.2014.06.026

Sauteur PM, Goetschel P, Lautenschlager S. Mycoplasma pneumoniae and mucositis--part of the Stevens-Johnson syndrome spectrum. J Dtsch Dermatol Ges. 2012;10(10):740-6. https://doi.org/10.1111/j.1610-0387.2012.07951.x PMid:22672205 DOI: https://doi.org/10.1111/j.1610-0387.2012.07951_suppl.x

Prindaville B, Newell BD, Nopper AJ, Horii KA. Mycoplasma pneumonia--associated mucocutaneous disease in children: Dilemmas in classification. Pediatr Dermatol. 2014;31(6):670-5. https://doi.org/10.1111/pde.12482 PMid:25424207 DOI: https://doi.org/10.1111/pde.12482

Patel R, Mohan A, Omar N, Pardi M. Drug-induced erythema multiforme major in an elderly female. J Community Hosp Intern Med Perspect. 2022;12(3):71-4. https://doi.org/10.55729/2000-9666.1057 PMid:35711389 DOI: https://doi.org/10.55729/2000-9666.1057

Shah SN, Chauhan GR, Manjunatha BS, Dagrus K. Drug induced erythema multiforme: Two case series with review of literature. J Clin Diagn Res. 2014;8(9):ZH01-4. https://doi.org/10.7860/JCDR/2014/10173.4761 PMid:25386550 DOI: https://doi.org/10.7860/JCDR/2014/10173.4761

Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: A review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin North Am. 2013;57(4):583-96. https://doi.org/10.1016/j.cden.2013.07.001 PMid:24034067 DOI: https://doi.org/10.1016/j.cden.2013.07.001

Aurelian L, Ono F, Burnett J. Herpes simplex virus (HSV)- associated erythema multiforme (HAEM): A viral disease with an autoimmune component. Dermatol Online J. 2003;9(1):1. PMid:12639459 DOI: https://doi.org/10.5070/D37V35W30D

Kim MJ, Kim JW, Kim MS, Choi SY, Na JI. Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech). J Eur Acad Dermatol Venereol. 2022;36(2):e98-100. https://doi.org/10.1111/jdv.17757 PMid:34661942 DOI: https://doi.org/10.1111/jdv.17757

Batta S, Miller AC, Adjei S, Temiz LA, Tyring SK. Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech). Proc (Bayl Univ Med Cent). 2022;35(6):811-2. https://doi.org/10.1080/08998280.2022.2097572 PMid:36304618 DOI: https://doi.org/10.1080/08998280.2022.2097572

Katayama S, Ota M. Erythema multiforme after BNT162b2 vaccination. Intern Med. 2022;61(12):1929. https://doi.org/10.2169/internalmedicine.9544-22 PMid:35431308 DOI: https://doi.org/10.2169/internalmedicine.9544-22

Kothari RS, Subramani D, Asnani DR, Raman A, Deora MS, Gupta A. Erythema multiforme after Covishield/ChAdOx1 vaccination. Dermatol Ther. 2022;35(3):e15289. https://doi.org/10.1111/dth.15289 PMid:34962029 DOI: https://doi.org/10.1111/dth.15289

Lopes NT, Pinilla CE, Gerbase AC. Erythema multiforme after CoronaVac vaccination. J Eur Acad Dermatol Venereol. 2021;35(11):e717-9. https://doi.org/10.1111/jdv.17495 PMid:34236724 DOI: https://doi.org/10.1111/jdv.17495

Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, et al. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol. 2006;155(4):722-8. https://doi.org/10.1111/j.1365-2133.2006.07398.x PMid:16965421 DOI: https://doi.org/10.1111/j.1365-2133.2006.07398.x

Nassif A, Moslehi H, Le Gouvello S, Bagot M, Lyonnet L, Michel L, et al. Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol. 2004;123(5):850-5. https://doi.org/10.1111/j.0022-202X.2004.23439.x PMid:15482470 DOI: https://doi.org/10.1111/j.0022-202X.2004.23439.x

Ho AW, Kupper TS. Fitzpatrick’s Dermatology. Soluble Mediators of the Cutaneous Immune System. 9th ed., Vol. 1. United States: McGraw Hill Education; 2019.

Akkurt ZM, Uçmak D, Türkcü G, Yüksel H, Yildiz K, Arıca M. Expression of interleukin-17 in lesions of erythema multiforme may indicate a role for T helper 17 cells. Cent Eur J Immunol. 2014;39(3):370-6. https://doi.org/10.5114/ceji.2014.45950 PMid:26155150 DOI: https://doi.org/10.5114/ceji.2014.45950

Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: Potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm. 2013;2013:165974. https://doi.org/10.1155/2013/165974 PMid:23853427 DOI: https://doi.org/10.1155/2013/165974